Cefoperazone prevents the inactivation of α1-antitrypsin by activated neutrophils

被引:10
作者
Dallegri, F [1 ]
Dapino, P [1 ]
Arduino, N [1 ]
Bertolotto, M [1 ]
Ottonello, L [1 ]
机构
[1] Univ Genoa, Sch Med, Dept Internal Med, I-16132 Genoa, Italy
关键词
D O I
10.1128/AAC.43.9.2307
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
At sites of neutrophilic inflammation, tissue injury by neutrophil elastase is favored by phagocyte-induced hypochlorous acid dependent inactivation of the natural elastase inhibitor alpha(1)-antitrypsin. In the present study, cefoperazone prevented alpha(1)-antitrypsin inactivation by neutrophils and reduced the recovery of hypochlorous acid from these cells. Moreover, the antibiotic reduced the free elastase activity in a neutrophil suspension supplemented with alpha(1)-antitrypsin without affecting the cells' ability to release elastase. These data suggest that the drug inactivates hypochlorous acid before its reaction with alpha(1)-antitrypsin, thereby permitting the antiprotease-mediated blockade of released elastase. In conclusion, cefoperazone appears to have the potential for limiting elastase-antielastase imbalances, attenuating the related tissue injury at sites of inflammation.
引用
收藏
页码:2307 / 2310
页数:4
相关论文
共 34 条
[1]   PROTEOLYTIC INACTIVATION OF ALPHA-1-ANTITRYPSIN AND ALPHA-1-ANTICHYMOTRYPSIN BY NEUTROPHILS IN ARTHRITIC JOINTS [J].
ABBINK, JJ ;
KAMP, AM ;
NUIJENS, JH ;
SWAAK, TJG ;
HACK, CE .
ARTHRITIS AND RHEUMATISM, 1993, 36 (02) :168-180
[2]  
Bainton DF., 1992, Inflammation: basic principles and clinical correlates, V2nd ed., P303
[3]   PROTECTION BY ANTIBIOTICS AGAINST MYELOPEROXIDASE-DEPENDENT CYTOTOXICITY TO LUNG EPITHELIAL-CELLS INVITRO [J].
CANTIN, A ;
WOODS, DE .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :38-45
[4]   Oxidant-scavenging activities of beta-lactam agents [J].
Carreer, R ;
Deby-Dupont, G ;
Deby, C ;
Jadoul, L ;
Mathy, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (01) :43-46
[5]   ALPHA-1-ANTITRYPSIN - MOLECULAR PATHOLOGY, LEUKOCYTES, AND TISSUE-DAMAGE [J].
CARRELL, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06) :1427-1431
[6]  
CLARK RA, 1981, J BIOL CHEM, V256, P3348
[7]  
DALLEGRI F, 1992, J RHEUMATOL, V19, P419
[8]  
DALLEGRI F, 1987, BLOOD, V70, P1743
[9]  
DALLEGRI F, 1997, INFLAMM RES, V46, P383
[10]  
DOHERTY JB, 1986, NATURE, V322, P192, DOI 10.1038/322192a0